Company Filing History:
Years Active: 2017-2019
Title: Bernard Delpech: Innovator in Cancer Treatment
Introduction
Bernard Delpech is a notable inventor based in Clamart, France. He has made significant contributions to the field of cancer treatment through his innovative research and patented inventions. With a total of 2 patents, Delpech is recognized for his work in developing novel compounds aimed at combating cancer and related diseases.
Latest Patents
Delpech's latest patents include the use of a novel 3-aryl-4-catechol-pyrrole-N-propanol compound and its derivatives to treat cancer and diseases associated with excessive angiogenesis. This invention focuses on a compound with a general formula that includes various aryl and alkyl groups, which can be utilized as a drug or prodrug in cancer treatment. Another significant patent involves N-substituted 3,4-bis(catechol) pyrrole compounds, which are designed for the treatment of cancer, highlighting the versatility and potential of his research in pharmaceutical applications.
Career Highlights
Bernard Delpech is affiliated with the Centre National de la Recherche Scientifique, where he conducts his research. His work has been instrumental in advancing the understanding of compounds that can effectively target cancer cells and inhibit angiogenesis, which is crucial for tumor growth.
Collaborations
Delpech has collaborated with notable colleagues such as Pascal Collin and Joanna Bakala, contributing to a dynamic research environment that fosters innovation and discovery in the field of cancer treatment.
Conclusion
Bernard Delpech's contributions to cancer research through his patented inventions demonstrate his commitment to advancing medical science. His innovative approaches have the potential to significantly impact the treatment of cancer and improve patient outcomes.